PATENT CLAIM ANALYSIS

Application Number: 15895976
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["800", "024000"]

Abstract:
The present invention provides methods for making reconstructed diploid human oocytes comprising the diploid genome of a human somatic cell, and also methods for making human nuclear transfer embryos, human embryonic stem cells, and human differentiated cells therefrom. The present invention also provides reconstructed human oocytes, human nuclear transfer embryos, human embryonic stem cells, and differentiated cells made using such methods, as well as compositions and kits useful in performing such methods.

Claim (Index 6):
The method of  claim 5 , wherein the fusogenic agent is used at the minimum concentration sufficient to induce cell fusion.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 88.0
- Lexical Diversity: 2.025
- Patent Class: 800.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14775594', '14276810', '14098424', '15253781', '10494074']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6715546432874187
- 35 USC 102 Novelty (BERT): 0.6928617308167496
- Combined Prediction Score: 0.6736853520403517
- Mean Citation Score: 468.14323
- Max Citation Score: 728.11115
- Similarity Product: 724.1021418551205

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test